This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for IDIS World Medicines.
Company Overview
IDIS is the leading authority in the field of named-patient medicine sourcing and supply. Having built an impressive reputation as a reliable and ethical source of named-patient medicines; IDIS prides itself on helping to provide a lifeline to patients and the medical profession.
IDIS supports pharmacists and physicians globally by sourcing and supplying medicines on an ethical named-patient basis. Working with IDIS provides you with instant access to a multitude of global avenues to fulfil your named-patient medicine requirements.
IDIS works in partnership with the pharmaceutical and biotechnology industry to establish and deliver pre-launch named-patient management programmes, develop solutions for a discontinued brand, manage temporary supply problems and source and supply medicines for clinical trials.
IDIS has specialist in-house expertise in legal and regulatory requirements, technical and clinical support, pharmacovigilance, import/export requirements and distribution and storage to deal with the complexities associated with handling named-patient medicines in an ethical and professional manner.
Overview of Activities
Named-patient Medicines
The supply of unlicensed medicines is highly regulated. However, in certain circumstances they can be supplied on a named-patient basis. For example:-
- If they have yet to gain a license for use in a specific disease area
- If they have yet to be licensed by the regulatory body
- If they are classified as an orphan drug
Pre-launch named-patient management programmes
Structured named-patient management programmes are an ethical and responsible way for pharmaceutical companies to manage pre-launch demand.
IDIS works in partnership with pharmaceutical and biotechnology companies to exclusively implement named-patient programmes for the distribution of specific pre-launch medicines and has been managing the complexities on their behalf for over 18 years.
Working in partnership with IDIS allows companies to remain in complete control of their pre-launch programme, while the day-to-day management and logistical factors are taken care of.
IDIS' capabilities revolve around the ability to tailor each programme individually, enabling the company to respond to demand ethically whilst ensuring appropriate use, indication and price of their drug and generating additional safety data.
Discontinuation Management
Discontinuation at the end of a product's lifecycle is a necessity for pharmaceutical companies but can be painful for prescribers and pharmacists. Sensitive management of a brand discontinuation is vital but, this can often be a substantial burden on internal resources which would otherwise be used to concentrate on up and coming medicines.
IDIS have extensive experience in managing discontinuations and can remove the burden of supplying discontinued medicines from pharmaceutical companies worldwide.
IDIS' capabilities to manage an unlicensed medicine programme on the company's behalf can reduce the impact the discontinuation has on the company, along with assisting in the effective communication to all parties involved casting the manufacturers in a very positive light.
Temporary Supply Management
The impact of a supply chain interruption can be devastating especially for the patient and prescriber who are likely to be the last to know.
IDIS can help support companies who find themselves facing a supply shortage by stepping in with a named-patient supply solution.
IDIS' support includes: 
- Locating alternative product
- Importing the medicine and dealing with the intricacies involved in distributing a controlled medicine
- Supplying it directly to healthcare professionals
- Monitoring demand levels
Working in collaboration with regulatory bodies and managing communication with patients, healthcare professionals and pharmaceutical companies.
Clinical Trial procurement
Clinical studies require detailed co-ordination and finding a suitable comparator product can often be a time-consuming element of this task.
IDIS are specialists in sourcing the required medicines. With global connections and expertise, capabilities to deliver language specific packaging, established systems to capture accurate market intelligence at any stage IDIS can assist you managing the supply of comparator, IDIS excels at providing you with a first-class, ethical tailored service appropriate to your needs.
IDIS recognises the impact that Clinical Trial Directives have on the supply of medicines for clinical trials. In-house clinical trial regulatory experts ensure IDIS conforms to all legislation and offers a compliance advisory service.
Seventeen out of the top 20 pharmaceutical companies and major contract research organisations trust IDIS as their preferred supplier for comparator drugs.
